Impact of Loco-regional Surgical Control on Survival of Extremity Soft Tissue Sarcoma among Patients of Hadhramout National Cancer Center
Advances in Surgical Sciences
Volume 7, Issue 1, June 2019, Pages: 15-20
Received: Dec. 23, 2018;
Accepted: Jan. 23, 2019;
Published: Feb. 15, 2019
Views 285 Downloads 42
Salah Ahmed Binziad, Department of Surgery, College of Medicine, Hadhramout University, Mukalla, Hadhramout, Yemen
Abdulla Saleh Alyamani, Department of Surgery, College of Medicine, Hadhramout University, Mukalla, Hadhramout, Yemen
Khalid Ahmed Baeesa, Department of Orthopedic Surgery, College of Medicine, Hadhramout University, Mukalla, Hadhramout, Yemen
Waleed Khaled Kaleem, Department of Clinical Oncology, Faculty of Medicine, Hadhramout University, Mukalla, Hadhramout, Yemen
Adnan Abdullah Bakarman, Department of Hematology, Faculty of Medicine Hadhramout University, Mukalla, Hadhramout, Yemen
Moutez Alyazedi, Family Medicine, Faculty of Medicine, Hadhramout University, Mukalla, Hadhramout, Yemen
Follow on us
Background: Loco-regional surgery remains the mainstay therapy of extremity soft tissue sarcoma (ESTS) and provides the only chance of cure. Improvements of surgical technique, increased surgical experience, radiotherapy, adjuvant and neoadjuvant chemotherapy increased the survival. Aim of study: to evaluate the effect of the type of surgical intervention on the survival and quality of life of ESTS Patients. Methods: This is a prospective study to evaluate the impact of loco-regional surgical control on the survival among ESTS patients attended the National Cancer Center, Hadhramout -Yemen, between April 2010 and October 2018. Extremity soft tissue sarcoma patients were operated either by wide-local excision with safety margin or amputation or disarticulation. The study population consisted of 52 patients in which males and females represented (53.85%) and (46.15%) respectively. The three variable methods were compared using Chi-square test. Survival rate was analyzed by Kaplan-Meier test. Results: Fifty two patients, 12 patients in Group I (23, 1%), 10 patients in Group II (19.2%) and 30 patient’s in Group III (57.7%). The mean survival in patients underwent disarticulation was (77.5) months, while patients who had an amputation, the survival was (45.5) months, and in wide local resection patients was (59.9) months. The mean overall survival was (65.9) months, P value > (0.026) which was significant. Among the 3 different types of management, high overall survival rate was found in patients underwent disarticulation, while overall survival rate was also high in patient underwent wide local excision or compartmental resection in spite of functional limb preservation and good quality of life. The mean overall survival rate was low in patients who had limb amputation with loss of limb function. Conclusion: The wide local excision or compartmental resection mandates margin-negative, accepted post-operative local wound complication, associated with prolonged disease-free-survival and overall survival than other methods. Must be deal with improve patient overall survival, decrease local recurrence and obtained best Oncological outcome by preserve function with good quality of life for ESTS patients who underwent wide or compartmental resection or radical limb sparing surgery.
Extremity Soft Tissue Sarcoma, Overall Survival, Local Control, Outcome
To cite this article
Salah Ahmed Binziad,
Abdulla Saleh Alyamani,
Khalid Ahmed Baeesa,
Waleed Khaled Kaleem,
Adnan Abdullah Bakarman,
Impact of Loco-regional Surgical Control on Survival of Extremity Soft Tissue Sarcoma among Patients of Hadhramout National Cancer Center, Advances in Surgical Sciences.
Vol. 7, No. 1,
2019, pp. 15-20.
Copyright © 2019 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/
) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Ferrone ML, Raut CP. Modern Surgical Therapy: Limb Salvage and the Role of Amputation for Extremity Soft-Tissue Sarcomas. Surg Oncol Clin N Am. 2012; 21 (2): 201-213. doi:10.1016/j.soc.2011.11.001.
Brennan M, Alektiar KM, Maki RG. Soft tissue sarcoma. In: DeVita VT, Hellmann S, Rosenberg SA, editors. Cancer: principles and practice of oncology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001: 1844–1891.
Wardrop J. Observations on fungus haematodes or soft cancer. Edinburgh: G Ramsay; 1809.
Erstad D, Ready J, Abraham J, et. Al. Amputation for Extremity Sarcoma: Contemporary Indications and Outcomes. Annals of Surgical Oncology. 2018 vol: 25 (2) pp: 394-403. Doi; 10.1245/s10434-017-6240-5.
Fletcher C, Bridge JA Hogendoorn P, Mertens F (eds) (2013) WHO Classification of tumours of soft tissue and bone, 4th edn. IARC Press, Lyon.
Smith HG, Thomas JM, Smith MJF, Hayes AJ, Strauss DC. Major Amputations for Extremity Soft-Tissue Sarcoma. Ann SurgOncol. 2018; 25 (2): 387-393. doi:10.1245/s10434-017-5895-2.
Shiu MH, Castro EB, Hajdu SI, Fortner JG. Surgical treatment of 297 soft tissue sarcomas of the lower extremity. Ann Surg. 1975; 182 (5): 597-602. doi:10.1097/00000658-197511000-00011.
Parsons CM, Pimiento JM, Cheong D, et al. The role of radical amputations for extremity tumors: A single institution experience and review of the literature. J SurgOncol. 2012; 105 (2): 149-155. doi:10.1002/jso.22067.
Yang JC, Chang AE, Baker AR, et al. Randomized prospective study of the benefit of adjuvant radiation therapy in the treatment of soft tissue sarcomas of the extremity. J Clin Oncol. 1998; 16 (1):197-203. doi:10.1200/JCO.19126.96.36.199.
Dancsok AR, Asleh-Aburaya K, Nielsen TO. Advances in sarcoma diagnostics and treatment. Oncotarget. 2017; 8 (4). doi:10.18632/oncotarget.12548.
Wibmer C, Leithner A, Zielonke N, Sperl M WR. Increasing incidence rates of soft tissue sarcomas? A population-based epidemiologic study and literature review. l. Ann Onco. 2010; 21 (1): 1106-1111.
Khan MM, 1, Waqar SH, et al. Surgical Management of Soft Tissue Sarcoma. J Rawalpindi Med Coll (JRMC. 2018; 22 (1): 58-62.
Bonvalot S, Rimareix F, Paumier A, Roberti E, Bouzaiene H, Le Péchoux C. Actualisation de la stratégie thérapeutique locorégionale dans les sarcomes des tissusmous et les tumeursdesmoïdes des membres. Cancer/Radiothérapie. 2010; 14 (6-7): 455-459. doi:10.1016/j.canrad.2010.06.016.
Parikh RC, Lorenzo M, Hess LM, Candrilli SD, Nicol S, Kaye JA. Treatment patterns and survival among older adults in the United States with advanced soft-tissue sarcomas. Clin Sarcoma Res. 2018; 8 (1): 8. doi:10.1186/s13569-018-0094-x.